These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16972502)

  • 1. The tobacco industry's response to the COMMIT Trial: an analysis of legacy tobacco documents.
    Carlini BH; Patrick DL; Halperin AC; Santos V
    Public Health Rep; 2006; 121(5):501-8. PubMed ID: 16972502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry.
    White J; Bero LA
    Am J Public Health; 2004 Feb; 94(2):240-50. PubMed ID: 14759933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco industry allegations of "illegal lobbying" and state tobacco control.
    Bialous SA; Fox BJ; Glantz SA
    Am J Public Health; 2001 Jan; 91(1):62-7. PubMed ID: 11189827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the tobacco industry documents for public health and policy.
    Bero L
    Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tobacco industry's use of Wall Street analysts in shaping policy.
    Alamar BC; Glantz SA
    Tob Control; 2004 Sep; 13(3):223-7. PubMed ID: 15333876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The tobacco industry's internal documents and smoking prevention in Spain].
    Soto-Mas F; Villalbí JR; Granero L; Jacobson H; Balcazar H
    Gac Sanit; 2003; 17 Suppl 3():9-14. PubMed ID: 14980182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turning negative into positive: public health mass media campaigns and negative advertising.
    Apollonio DE; Malone RE
    Health Educ Res; 2009 Jun; 24(3):483-95. PubMed ID: 18948569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions.
    Lopipero P; Bero LA
    Tob Control; 2006 Aug; 15(4):323-32. PubMed ID: 16885582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From legitimate consumers to public relations pawns: the tobacco industry and young Australians.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii71-8. PubMed ID: 14645951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "We Card" program: tobacco industry "youth smoking prevention" as industry self-preservation.
    Apollonio DE; Malone RE
    Am J Public Health; 2010 Jul; 100(7):1188-201. PubMed ID: 20466965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outing of Philip Morris: advertising tobacco to gay men.
    Smith EA; Malone RE
    Am J Public Health; 2003 Jun; 93(6):988-93. PubMed ID: 12773366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco industry attempts to frame smoking as a 'disability' under the 1990 Americans with Disabilities Act.
    van der Eijk Y; Glantz SA
    PLoS One; 2017; 12(11):e0188188. PubMed ID: 29176829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marketing to America's youth: evidence from corporate documents.
    Cummings KM; Morley CP; Horan JK; Steger C; Leavell NR
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I5-17. PubMed ID: 11893810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Playing hide-and-seek with the tobacco industry.
    LeGresley EM; Muggli ME; Hurt RD
    Nicotine Tob Res; 2005 Feb; 7(1):27-40. PubMed ID: 15804675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.
    Gundle KR; Dingel MJ; Koenig BA
    Addiction; 2010 Jun; 105(6):974-83. PubMed ID: 20659058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of tobacco control activities in 11 north American communities: life after the Community Intervention Trial for Smoking Cessation (COMMIT).
    Lichtenstein E; Thompson B; Nettekoven L; Corbett K
    Health Educ Res; 1996 Dec; 11(4):527-34. PubMed ID: 10163959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study.
    Cataldo JK; Bero LA; Malone RE
    J Clin Epidemiol; 2010 Aug; 63(8):841-53. PubMed ID: 20630333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.